Chicago-area AbbVie is among eight U.S. companies planning inversions and has large amounts of foreign earnings held in cash; the new Treasury rules would restrict inverted companies’ access to those funds.

http://www.bloomberg.com/news/2014-09-23/u-s-rule-targets-medtronic-tax-free-use-of-foreign-cash.html